[1]杨帆,综述,张剑宁,等.长链非编码RNA在胶质瘤中的研究进展[J].中国临床神经外科杂志,2022,27(06):508-509512.[doi:10.13798/j.issn.1009-153X.2022.06.028]
点击复制

长链非编码RNA在胶质瘤中的研究进展()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
27
期数:
2022年06期
页码:
508-509512
栏目:
综述
出版日期:
2022-06-30

文章信息/Info

文章编号:
1009-153X(2022)06-0508-02
作者:
杨帆综述张剑宁审校
100048 北京 中国人民解放军总医院第一医学中心神经外科医学部(杨帆、张剑宁)
关键词:
胶质瘤长链非编码RNA病理预后分子标记物
分类号:
R739.41;Q786
DOI:
10.13798/j.issn.1009-153X.2022.06.028
文献标志码:
A

参考文献/References:

[1] Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary [J]. Acta Neuropathol, 2016, 131(6): 803-820.
[2] Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function [J]. Nat Rev Genet, 2016, 17(1): 4762.
[3] Oe S, Kimura T, Yamada H. Regulatory non-coding RNAs in nervous system development and disease [J]. Front Biosci(Landmark Ed), 2019, 24: 1203-1240.
[4] Zhao QS, Ying JB, Jing JJ, et al. LncRNA FOXD2-AS1 stimulates glioma proression through inhibiting P53 [J]. Eur Rev Med Pharmacol Sci, 2020, 24(8): 4382-4388.
[5] Huang L, Li X, Ye H, et al. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis [J]. J Exp Clin Cancer Res, 2020, 39(1): 63.
[6] Shangguan W, Lv X, Tian N. FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide residtance in a O6-methylguanine-DNA methyltransferase-dependent manner [J]. Korean J Physiol Pharmacol, 2019, 23(6): 475-482.
[7] Du P, Zhao H, Peng R, et al. LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway [J]. Biosci Rep, 2017, 37(5): BSR20170696.
[8] Jia P, Cai H, Liu X, et al. Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma associated endothelial cells by inhibiting micro-RNA-29a [J]. Cancer Lett, 2016, 381(2): 359-369.
[9] Wang L, He Z. Functional roles of long non-coding RNAs (LncRNAs) in glioma stem cells [J]. Med Si Monit, 2019, 25:7567-7573.
[10] Sa L, Li Y, Zhao L, et al. The role of HOTAIR/miR-148b-3p/USF1 on regulating the permeability of BTB [J]. Front Mol Neurosci, 2017, 10: 194.
[11] Wang W, Zhao Z, Yang F, et al. An immune-related lncRNA signature for patients with anaplastic glioma [J]. J Neurooncol, 2018, 136(2): 263-271.
[12] Li M, Long S, Hu J, et al. Systematic identification of lncRNA-based peognostic biomarkers for glioblastoma [J]. Aging (Albany NY), 2019, 11(21): 9405-9423.
[13] Guardia GDA, Correa BR, Araujo PR, et al. Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles [J]. NPJ Genom Med, 2020, 5:2.
[14] Xiao Y, Zhu Z, Li J, et al. Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses [J]. Aging (Albany NY), 2020, 12(4):3407-3430.
[15] Xiao H, Ding N, Liao H, et al. Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients [J]. Medicine (Baltimore), 2019, 98(45): e17583.
[16] Min W, Dai D, Wang J, et al. Long noncoding RNA miR210HG as a potential biomarker for the diagnosis of glioma [J]. PloS One, 2016, 11(9): e0160451.
[17] Qin WX, Shi Y, Zhu D, et al. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p [J]. Eur Rev Med Pharmcol Sci, 2020, 24(6): 3204-3214.
[18] Liu SJ, Malatesta M, Lien BV, et al. CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma [J]. Genome Biol, 2020, 21(1):83.
[19] Peng L, Chen Z, Chen Y, et al. MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancer[J]. Cancer Med, 2019, 8(17): 7161-7173.

相似文献/References:

[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
 CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(06):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
 XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
 LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
 YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
 HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
 DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(06):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
 PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(06):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
 FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(06):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[11]谈胤求 陈谦学 张红波 吴 鹏 李云涛 王栋良 袁凡恩.长链非编码RNA PVT1对人脑胶质瘤U251细胞增殖能力的影响[J].中国临床神经外科杂志,2016,(10):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
 TAN Yin-qiu,CHEN Qian-xue,ZHANG Hong-bo,et al.Effect of lncRNA-PVT1 on proliferation of glioma U251 cells[J].,2016,(06):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
[12]陈 波 云亚滨 杜俊峰 王伟志.lncRNA SNHG16对胶质瘤U251细胞增殖、侵袭和迁移的影响[J].中国临床神经外科杂志,2020,(11):771.[doi:doi:10.13798/j.issn.1009-153X.2020.11.012]
 CHEN Bo,YUN Ya-bin,DU Jun-feng,et al.Effect of lncRNA SNHG16 on proliferation, invasion and migration of glioma U251 cells[J].,2020,(06):771.[doi:doi:10.13798/j.issn.1009-153X.2020.11.012]
[13]孙青青 任洪波 牛国栋.lncRNA SNHG16在人脑胶质瘤组织中的表达及其与病人预后的关系[J].中国临床神经外科杂志,2020,(12):831.[doi:10.13798/j.issn.1009-153X.2020.12.005]
 SUN Qing-qing,REN Hong-bo,NIU Guo-dong..Expression of lncRNA SNHG16 in human glioma tissues and its relationship with prognosis of glioma patients[J].,2020,(06):831.[doi:10.13798/j.issn.1009-153X.2020.12.005]
[14]郑江林 王 旋 汪珉杰 姜晓兵.人脑胶质瘤lncRNA PIK3CD-AS2表达及临床意义[J].中国临床神经外科杂志,2021,26(09):687.[doi:10.13798/j.issn.1009-153X.2021.09.011]
 ZHENG Jiang-lin,WANG Xuan,WANG Min-jie,et al.Expression of lncRNA PIK3CD-AS2 in human brain gliomas and its clinical significance[J].,2021,26(06):687.[doi:10.13798/j.issn.1009-153X.2021.09.011]
[15]李占成 石 铁 周卫忠.胶质瘤自噬相关长链非编码RNA的生信分析[J].中国临床神经外科杂志,2021,26(11):839.[doi:10.13798/j.issn.1009-153X.2021.11.007]
 LI Zhan-cheng,SHI Tie,ZHOU Wei-zhong.Autophagy-related long non-coding RNA signature in glioma patients based on bioinformatics analysis[J].,2021,26(06):839.[doi:10.13798/j.issn.1009-153X.2021.11.007]
[16]陈操,综述,陈铎,等.lncRNA在胶质瘤放化疗中作用的研究进展[J].中国临床神经外科杂志,2022,27(07):610.[doi:10.13798/j.issn.1009-153X.2022.07.029]
[17]王昆鹏,张建党,董孟宁,等.lncRNA SNHG7对胶质瘤细胞侵袭、迁移的影响[J].中国临床神经外科杂志,2022,27(08):662.[doi:10.13798/j.issn.1009-153X.2022.08.012]
 WANG Kun-peng,ZHANG Jian-dang,DONG Meng-ning,et al.[J].,2022,27(06):662.[doi:10.13798/j.issn.1009-153X.2022.08.012]
[18]丁萌,王红娟,周洁,等.lncRNA ZNF674-AS1过表达对胶质瘤U87细胞增殖、侵袭和迁移的影响[J].中国临床神经外科杂志,2022,27(10):837.[doi:10.13798/j.issn.1009-153X.2022.10.012]
 DING Meng,WANG Hong-juan,Zhou Jie,et al.Effects of over-expression of lncRNA ZNF674-AS1 on proliferation, invasion and migration of U87 glioma cells[J].,2022,27(06):837.[doi:10.13798/j.issn.1009-153X.2022.10.012]

备注/Memo

备注/Memo:
(2020-05-20收稿,2020-08-17修回)
通讯作者:张剑宁,E-mail:jnzhang@yahoo.com.cn
更新日期/Last Update: 2022-07-31